John G Cramer to become first human recipient of bioreactor-grown mitochondria in an early-stage longevity study led by Mitrix Bio.
longevity.technology/news/physicist…
#longevity #biotech #mitochondria #agex #healthspan #clinicaltrial #biohacking #futureofaging
Longevity Technology
5,817 posts
Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
- Crypto #airdrop to support #SENS Research Foundation... New #crypto currency #Pulse set to boost #antiaging research. #longevity #investment @RichardHeartWin @aubreydegrey @senstweet longevity.technology/crypto-airdrop…
- Longevity.Technology’s most-read stories of 2021. We reflect on our most popular stories of the year. #longevity #technology #aging #agetech #supplements @BKennedy_aging @kapahi_pankaj @davidasinclair @nutriop @EricVerdin longevity.technology/longevity-tech…
- NewLimit restores ‘youthful function’ to liver and immune cells @byersblake #longevity #healthspan #reprogramming #aging longevity.technology/news/newlimit-…
- China’s only XPRIZE Healthspan Top 40 team is aiming for regenerative interventions that could extend healthy lifespan to 150 years. longevity.technology/news/prometheu… #longevity #aging #stemcells #regenerativemedicine #biotech #XPRIZE #ChinaInnovation
- John G Cramer is set to be the first person to receive lab-grown mitochondria as part of a pioneering longevity trial from Mitrix Bio. longevity.technology/news/physicist… #longevity #biotech #mitochondria #agex #healthspan #clinicaltrial #biohacking #futureofaging
- Germany calls for medicine to treat aging, not just disease #longevity #longevityeconomy longevity.technology/news/germany-c…
- Enzolytics partners with Khalpey #AI Lab on longevity #research initiative Texas-based biotech Enzolytics has joined forces with Khalpey AI Lab in a partnership aimed at advancing the fields of #organregeneration and #longevity. #digital longevity.technology/news/enzolytic…
- George Church lab spawns $75m cell therapy startup GC Therapeutics’ plug-and-play stem cell programming platform aims to reduce cell therapy development time by up to 100 times. #longevity #investment #celltherapy #stemcells #biotech longevity.technology/news/george-ch…
- Selective removal of toxic cholesterol restores immune function in foam cells, paving the way for human trials of novel compound UDP-003. longevity.technology/news/new-data-… #longevity #atherosclerosis #biotechnews #agingresearch #hearthealth #clinicaltrials #reversingaging
- Company plots Phase 3 trial of drug that targets a unique metabolic switch to ‘reawaken’ inactive stem cells and stimulate hair growth. longevity.technology/news/pelage-sw… #longevity #investment #biotech #hairloss #stemcells
- Stay cool: the #longevity tech that “shows insane promise” @aubreydegrey explains why the time is right to be extremely ambitious and audacious when it comes to longevity research. @LongevityDublin @longevityevf #event #conference #technology #longevity
- NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer to reality. longevity.technology/news/lilly-inv… #longevity #investment #biotech #pharma #rejuvenation
- Life Bio ready for world’s first partial epigenetic reprogramming trials New COO Michael Ringel says company is confident as it prepares for clinical studies in glaucoma and NAION later this year. @davidasinclair #longevity #biotech #reprogramming #aging longevity.technology/news/life-bio-…












